SI
PHVS icon

Sofinnova Investments’s Pharvaris PHVS Stock Holding History

Sofinnova Investments’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.5M Buy
881,299
+62,971
+8% +$1.91M 1.58% 23
2026
Q1 		$23.1M Buy
818,328
+73,159
+10% +$1.95M 0.88% 35
2025
Q4 		$20.7M Buy
745,169
+5,293
+0.7% +$127K 0.89% 35
2025
Q3 		$18.5M Buy
739,876
+154,344
+26% +$3.42M 1.01% 31
2025
Q2 		$10.3M Sell
585,532
-7,871
-1% -$127K 0.63% 40
2025
Q1 		$9.32M Buy
593,403
+32,680
+6% +$551K 0.61% 40
2024
Q4 		$10.7M Sell
560,723
-39,579
-7% -$815K 0.78% 32
2024
Q3 		$11.1M Sell
600,302
-1,232
-0.2% -$22.5K 0.88% 27
2024
Q2 		$11.3M Buy
601,534
+16,862
+3% +$343K 0.59% 41
2024
Q1 		$13.5M Buy
584,672
+74,231
+15% +$1.97M 0.75% 33
2023
Q4 		$14.3M Buy
+510,441
New +$10.3M 0.8% 30

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Sofinnova Investments's PHVS Position: Q2 2026 in Review

Sofinnova Investments increased its Pharvaris (PHVS) stake by 7.7% in Q2 2026, buying an estimated $1.91M and bringing the position to 881,299 shares worth $30.5M. The position accounts for 1.58% of the portfolio, ranked #23.

Sofinnova Investments first reported a position in PHVS in Q4 2023 and has held it in 11 quarters since. 125 funds tracked by Wall St. Rank hold PHVS as of Q2 2026.

  • Sofinnova Investments held 881,299 shares of Pharvaris worth $30.5M as of Q2 2026.
  • Sofinnova Investments bought 62,971 Pharvaris shares in Q2 2026, an estimated $1.91M.
  • Pharvaris made up 1.58% of Sofinnova Investments's portfolio in Q2 2026, its #23 holding.
  • Sofinnova Investments first reported a position in Pharvaris in Q4 2023 and has held it in 11 quarters since.
  • 125 funds tracked by Wall St. Rank held Pharvaris as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.